Beyond the Standard: Individualized Approaches to Dual Antiplatelet Therapy Gain Attention
Dirk Sibbing, Professor, Cardiologist and Angiologist at Privatklinik Lauterbacher Mühle and LMU Munich, shared an insightful post on LinkedIn:
”When it comes to dual antiplatelet treatment we are still using a non-individualized approach in our everyday clinical practice for patients after PCI.
However, evidence is accumulating that sex, age, BMI and many more variables may constitute relevant treatment effect modifiers for drugs like clopidogrel, prasugrel or ticagrelor.
See the latest data on DAPT and sex in the European Heart Journal and my Editorial that puts the findings into perspective.”
Read the full article here.
Article: Dual antiplatelet therapy modulation strategies beyond standard of care: a promising path towards individualized antiplatelet treatment
Author: Dirk Sibbing
Stay updated on all science in the field of hematology with Hemostasis Today.
-
Aug 12, 2025, 14:35Preventable Blood Clots Take Lives: Arshell Shares Her Daughter Leschel’s Tragic Story to Raise Awareness
-
Aug 12, 2025, 14:16Antonio Ciacciarelli: touchNEUROLOGY Future Leader 2025
-
Aug 12, 2025, 06:39Join an NHLBI Clinical Trial on Blood Clots, Inflammation, and Vascular Disease
-
Aug 11, 2025, 13:40Maxime Dely on Why Ethical Blood Donation Matters
-
Aug 11, 2025, 13:20WFH Humanitarian Aid Program Hosts Workshop on Hemophilia Diagnosis and Management in Türkiye
-
Aug 12, 2025, 11:08A Rare Case of Aortic Thrombosis in a Newborn With CDH
-
Aug 12, 2025, 03:37Low-Intensity DOACs in VTE: Sapienza University Reports Long-Term Outcomes
-
Aug 12, 2025, 02:00Arsene Mekinian։ International Vexas' Announcements Is Finally Published
-
Aug 12, 2025, 01:27Marco Pirisinu: Highlights Potential of PDEVs in Drug Delivery
-
Aug 11, 2025, 13:50Vascular Damage from Pancreatic Juice Leakage
-
Jul 28, 2025, 14:55HORIBA Decoding High Efficiency in Hematology Lab: Free Online Workshop
-
Jul 26, 2025, 17:56HIPEITHO Trial Achieves Remarkable Enrollment Milestone Across 72 Sites in the US and Europe
-
Jul 16, 2025, 15:04Toward Hemophilia Gene Therapy for All? Insights from Prof. Flora Peyvandi in Blood Advances
-
Jul 14, 2025, 16:39Dr. Philipp Bücke: MRI Proven as No.1 Choice for Accurate TIA Diagnosis
-
Jul 13, 2025, 16:05EMA and HMA Mark a Key Step with 1st AI Observatory Report
-
Aug 11, 2025, 05:16Andreas Calatzis: Any Information on Soviet Thrombelastographs?
-
Aug 9, 2025, 15:36NBCA: Blood Clot Survivor Runs 2025 NYC Marathon with Team Stop the Clot
-
Aug 8, 2025, 18:33Hemophilia Alliance during Tennessee Hemophilia and Bleeding Disorders Foundation Annual Meeting 2025
-
Aug 7, 2025, 14:49JAMA+AI Conversations: David Rhew's Journey from Clinical Practice to Technology Leadership
-
Aug 6, 2025, 16:47My Clot Story: Birth Control and A Life-threatening Pulmonary Embolism